Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03630042
Title Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia (PembroWM)
Acronym PembroWM
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Derriford Hospital, Univeristy Hospitals Plymouth NHS Trust Plymouth Devon PL6 8DH United Kingdom Details
Torbay and South Devon NHS Foundation Trust Torquay Devon TQ2 7AA United Kingdom Details
Royal Bournemouth Hospital, University Hospitals Dorset NHS Foundation Trust Bournemouth Dorset BH7 7DW United Kingdom Details
St Bartholomew's Hospital, Barts Health NHS Trust London Greater London EC1A 7BE United Kingdom Details
UCLH, Univeristy College London Hospitals NHS Foundation Trust London Greater London NW1 2PG United Kingdom Details
The Christie Hospital, The Christie NHS Foundation Trust Manchester Greater Manchester M20 4BX United Kingdom Details
Churchill Hospital, Oxford Univeristy NHS Foundation Trust Oxford Oxfordshire OX3 7LE United Kingdom Details
Bristol Haematology & Oncology Medical Centre, University Hospitals Bristol and Weston NHS Foundation Trust Bristol BS1 3NU United Kingdom Details
Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust Norwich NR4 7UY United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field